Roche Launches Updated cobas 6800/8800 Systems with Enhanced Testing Capabilities
The version 2.0 systems feature increased throughput, expanded assay flexibility, and the ability to run up to six unique assays per run.
Category: Molecular Diagnostic Analyzers
Molecular Diagnostic Analyzers
Latest
Molecular Diagnostic Analyzers
Latest
Natera’s Signatera Test Integrated into Phase III Bladder Cancer Trial
The ARCHER study will evaluate shortened radiation therapy while using ctDNA testing to monitor treatment response and disease recurrence.
Molecular Diagnostic Analyzers
Latest
PanTracer Tissue and PanTracer Tissue + HRD Are Now Available
NeoGenomics has launched PanTracer Tissue and PanTracer Tissue + HRD, advanced solid tumor profiling assays.
Empire Genomics Scores Molecular Analyzers, Reagents Agreement
Empire Genomics Corp. has been awarded a national group purchasing agreement for Molecular Analyzers, Reagents with Premier, Inc.
Read More
Post-Viral Syndromes and the Utility of T-cell Diagnostics
There is a potential to use T-cell diagnostics to diagnose underlying post-viral syndromes by measuring the bodies adaptive immune resistance.
Read More
FDA Clears Cardiac Troponin I Test for Myocardial Infarction Diagnosis
The new high-sensitivity troponin assay is designed for use on the the PATHFAST Biomarker Analyzer from Polymedco.
Read More
QIAGEN Upgrades its Syndromic Testing Analyzer
The QIAstat-Dx Analyzer 2.0 enables mobile access to test results, streamlining diagnostic processes and enhancing patient care.
Read More
BIOTYPE Upgrades Benchtop Diagnostic Platform for Multi-Gene Testing
BIOTYPE presented a major upgrade to its benchtop diagnostic platform for the fully integrated analysis of molecular biomarker signatures.
Read More
Roche Expands HPV Testing for Cobas 5800 Molecular System
Roche announced the U.S. FDA approved the cobas HPV test for use on its next-generation cobas 5800 molecular instrument.
Read More
AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage
CareDx, Inc. has announced that its AlloSure Lung donor-derived cell-free DNA molecular testing service has received Medicare coverage.
Read More
Molecular Imaging & Histology Combine for Better Cancer Diagnosis
Orion combines histologic with molecular imaging information and offers deeper insight into a tumor’s type.Â
Read More
New Centre for Phage Research features Actiphage
The first Centre for Phage Research launched on May 16 and featured in the Innovate UK KTN’s UK Phage Innovation Showcase will be Actiphage.
Read More
De Novo Submission Made for Full Clearance of its Cue RSV Molecular Test
Cue Health announced that it has made a De Novo submission to the FDA for full clearance of the Cue RSV Molecular Test.
Read More
PathogenDx Expands Reach of Multiplexed Molecular Testing Tech
PathogenDx expanded the reach of its patented multiplexed molecular testing technology, Dynamic Dimensional Detection (D3 Array).
Read More
Planned Parenthood Expands Access to STI Testing
Planned Parenthood Mar Monte (PPMM) has teamed with BD to provide STI testing for the most common infections to underserved populations.
Read More
The Opportunity to Upgrade Pharyngitis Testing
Pharyngitis testing and diagnosis can be improved by utilizing existing molecular testing capacity increased due to COVID.
Read More
As CML Outcomes Improve, Demand Rises for BCR::ABL1 Testing
Patients with chronic myeloid leukemia need regular BCR::ABL1 testing for the rest of their lives, which can translate into more lab work.
Read More
New Method for the Detection of RNA Viruses
Experts have developed a new methodology to detect RNA viruses based on the triplex-forming probe technology.
Read More